Rosuvastatin is cost-effective in treating patients to low-density lipoprotein-cholesterol goals compared with atorvastatin, pravastatin and simvastatin: analysis of the STELLAR trial (Q45259483)
Jump to navigation
Jump to search
scientific article published in February 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rosuvastatin is cost-effective in treating patients to low-density lipoprotein-cholesterol goals compared with atorvastatin, pravastatin and simvastatin: analysis of the STELLAR trial |
scientific article published in February 2005 |
Statements
1 reference
Rosuvastatin is cost-effective in treating patients to low-density lipoprotein-cholesterol goals compared with atorvastatin, pravastatin and simvastatin: analysis of the STELLAR trial (English)
1 reference
Mark Hirsch
1 reference
John C O'Donnell
1 reference
Peter Jones
1 reference
1 February 2005
1 reference
1 reference
12
1 reference
1
1 reference
18-28
1 reference
Identifiers
1 reference
1 reference